Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Zinc finger protein transcription factors show potential in treating pain

May 20, 2008

Novel analgesic agents described in recent patents

May 19, 2008

Pozen transfers IND and NDA for migraine drug Treximet to GSK

May 19, 2008

FDA puts Geron's IND application for GRNOPC1 on clinical hold

May 19, 2008

Wyeth's Pristiq available in U.S. pharmacies for major depressive disorder

May 16, 2008

Orexo submits NDA to the FDA for Sublinox (OX-22) for short-term insomnia

May 16, 2008

Pfizers's ziprasidone under study in children and adolescents with bipolar I disorder

May 16, 2008

Valeant reports positive results from phase III RESTORE 2 trial of retigabine in epilepsy

May 16, 2008

Alseres announces 12-month interim data from phase I/IIa clinical trial of Cethrin in SCI

May 16, 2008

FDA approves Seroquel for maintenance treatment in bipolar disorder

May 15, 2008

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...